The document provides operational guidelines for introducing the pentavalent vaccine (DPT + HepB + Hib) in the Universal Immunization Programme in India. Some key points:
1) The pentavalent vaccine protects against 5 diseases (diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b) in a single vaccine.
2) Guidelines are provided on training health workers, microplanning, monitoring coverage, reporting data, and communicating with caregivers about the new vaccine.
3) A phased approach is outlined to first introduce the vaccine in some states with support from the Government of India, before expanding nationwide. Close monitoring will help evaluate
It includes the five most common immunization vaccines for the infant and these are the BCG, DPT, OPV, Hep B and Measles and also the Tetanus Toxoid for both infant and mother.
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
the ppt describes the pentavalent and trivalent according to the national immunisation program,india in an easy to understand and interactive form.useful for students and tutors.
also has a FAQ section.
Universal Programme Immunization as per World Health Organisation in India with Cold Chain and Vaccine Storage in Overall Health Management for Children under 5 years of age
It includes the five most common immunization vaccines for the infant and these are the BCG, DPT, OPV, Hep B and Measles and also the Tetanus Toxoid for both infant and mother.
Immunization is single most important step towards control and elimination of infectious disease.
With regards to epidemiology and population demographics, various changes are made from time to time in Immunization Schedule of the National Health Programme.
This slide show encompasses the recent changes made by National Health Commission with regards to Immunization Schedule.
the ppt describes the pentavalent and trivalent according to the national immunisation program,india in an easy to understand and interactive form.useful for students and tutors.
also has a FAQ section.
Universal Programme Immunization as per World Health Organisation in India with Cold Chain and Vaccine Storage in Overall Health Management for Children under 5 years of age
this ppt describes the importance of medical entomolgy.contents are described using pictograms and photographs.useful for students of mbbs and for teaching purposes.
The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.
Nigeria's National Programme on ImmunisationEsther Ajari
This presentation gives a well-researched overview of Nigeria's National Programme on Immunization. The key areas covered include: Definition of terminologies, history, components, controversies, strategies, and guidelines.
AIDSTAR-One Implementation of WHO's 2008 Pediatric HIV Treatment GuidelinesAIDSTAROne
In April 2008, the WHO Technical Reference Group for Pediatric HIV/ART and Care released a series of nine updated recommendations for diagnostic testing, initiation of treatment, and appropriate treatment regimens for HIV-exposed and infected infants. This technical brief outlines practical implementation considerations for program planners and policymakers working to incorporate these recommendations into their local efforts.
http://www.aidstar-one.com/implementation_whos_2008_pediatric_hiv_treatment_guidelines
Quality of Care in a Health Facility is a major concern for Public Facilities in India. Quality Improvement Process should be driven by the Care Providers, Facility Managers and other Stakeholders integrating patient/client satisfaction and scientifically and technically sound treatment protocols.
Similar to Revised operational guidelines for Pentavalnet Launch12 sep 2014 (20)
Pentavalent Launch in Andhra Pradesh 31st October 2014 , Vijayawadadichmu
Pentavalent Andhra Pradesh State, ToT at Vijayawada
From Right_UNICEF representative-Dr,Sanjeev-,WHO,STL,NPSP-Comissioner Health and Family Welfare-Sri.Saurabh ,IAS,-Health Minister_sri.K.Sreenivas-MLA, Vijayawada-Director of Health-Smt.Geetha Prasadhini-Joint Director(Immunization)-Dr.Prasad-SSO,WHO,NPSP-Dr.Arun-
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
3. Operational Guidelines
Hib-containing Pentavalent Vaccine in the
Universal Immunization Programme
2014
Operational guidelines developed by theWHOCountry Office for India for Ministry of Health &
FamilyWelfare, Government of India
4.
5. CONTENTS
1. Background.............................................................................................................. 1
2. The disease - Haemophilus influenzae
type b........................................................... 5
Frequently asked questions - Haemophilus influenzae
type b.................................. 8
3. Hib-containing pentavalent vaccine......................................................................... 11
4. Programme-level actions and decisions to be taken................................................ 17
5. Steps for the inclusion of pentavalent vaccine in the Universal Immunization
Programme in India.................................................................................................. 25
6. Monitoring and supervision...................................................................................... 37
7. Frequently asked questions - Hib-containing pentavalent vaccine.......................... 43
1. Key findings and recommendations of post-introduction evaluation (PIE)
of pentavalent vaccine in India…………………………………………….................... 45
2. Pentavalent vaccine training workshop for medical officers at
state/district level....................................................................................................... 48
3. Pentavalent vaccine training workshop for data handlers at state/district level........ 51
4. Pentavalent vaccine training workshop for vaccine and cold chain handlers at
state/district level……………………………………………………………………........ 54
5. Pentavalent vaccine training workshop for ANMs, LHVs and health
supervisors at block level………………………………………………………….......... 57
6. Pentavalent vaccine training workshop for ASHAs/AWWs/link workers at
block level… 61
7. …… 64
Pentavalent vaccine Training workshop for iec/media Handling focal persons
……………………………………………………………………….................. 66
Annexures
References
9. 1. BACKGROUND
Pentavalent Vaccine in UIP
(5 antigens)
DPT + Hepatitis B + Hib
The force of five in one
1
Don’t Forget,
accination VYour baby must get!
10. Fig. 1. Pentavalent vaccine introduction in states with support from GoI
Pentavalent vaccine introduction and scale up
Pentavalent vaccine introduction - 8 States
Pentavalent vaccine proposed in 2014 - 12 states
2
S.No.
Pentavalent introduction
planned in 2014
Andhra Pradesh
Telangana
Assam
Bihar
Chattisgarh
Delhi
Jharkhand
Madhya Pradesh
Punjab
Rajasthan
Uttarakhand
West Bengal
1
2
3
4
5
6
7
8
9
10
11
12
19. Liquid
Vaccine
5ml
10 dose
vial
DPT + Hep B + Hib
VVM
3. Hib-CONTAINING
PENTAVALENT VACCINE
11
Don’t Forget,
accination VYour baby must get!
20. Table 1. Immunization schedule–current and post-pentavalent introduction
Age Current immunization
schedule (Prior to
pentavalent introduction)
Immunization schedule
(post pentavalent
introduction)
Remarks
At birth BCG, OPV (0 dose), hepati- BCG, OPV (0 dose),
Hepatitis B (birth dose) hepatitis B (birth dose)
12
to 1 year of age
(2) DPT vaccine
can be given
up to 5–6 years
(not beyond 7
years) of age
(3) Measles
vaccine can
be given up to
5 years of age
(4) JE vaccine can
be given up to 15
years of age.
6 weeks
(1 ½ months )
OPV-1, DPT-1, hepatitis B-1 OPV-1, pentavalent-1
10 weeks
(2 ½ months )
OPV-2, DPT-2, hepatitis B-2 OPV-2, pentavalent -2
14 weeks
(3 ½ months )
OPV-3, DPT-3, hepatitis B-3 OPV-3, pentavalent -3
9 months Measles first dose, JE-1
(where applicable)
Measles first dose, JE-1
(where applicable)
16–24 months DPT-booster first dose,
measles second dose, OPV
booster dose , JE second
dose (where applicable)
DPT-booster first dose,
measles second dose,
OPV booster dose, JE
second dose (where
applicable)
5–6 years DPT-booster second dose DPT-booster second dose
10 years TT first booster dose TT first booster dose
16 years TT second booster dose TT second booster dose
(1) BCG vaccine
can be given up
26. Remember
A maximum of 15 % wastage is
acceptable for Pentavalent and
all other vaccines that are eligible
for reuse as per open vial policy
guidelines.
18
27. M6 M10
19
Don’t Forget,
accination VYour baby must get!
Fig. 2. Reporting pentavalent vaccine coverage in the HMIS
CHILD IMMUNIZATION
Number of Infants 0 to 11 months old who received the following
BCG
DPT1
DPT2
DPT3
Pentavalent 1
Pentavalent 2
Pentavalent 3
OPV 0 (Birt Dose)
OPV 1
OPV 2
OPV 3
22
22.1
22.2
22.3
22.4
22.4A
22.4B
22.4C
22.5
22.6
22.7
22.8
10.1
10.1.01
10.1.02
10.1.03
10.1.04
10.1.04A
10.1.04B
10.1.04C
10.1.05
10.1.06
10.1.07
10.1.08
31. Four key messages for caregivers
• What vaccine was given and what diseases it prevents
• When and where to come for the next visit
• What minor adverse events could occur and how to
deal with them
• Keep the immunization card safe and bring it along at
the next visit.
23
Don’t Forget,
accination VYour baby must get!
32.
33. 5. STEPS FOR THE
INCLUSION OF PENTAVALENT
VACCINE IN THE UIP IN INDIA
25
Don’t Forget,
accination VYour baby must get!
34. Table 2.Checklist components
26
1. Human resource
vitals
2. Background
information
3. Microplanning status 4. Training status
5. Reporting and
recording practices
6. Vaccine coverage
and wastage
7. Vaccine management,
transport and logistics
8. Waste management
and injection safety
9. Monitoring and
evaluation
10. AEFI 11. Mobilization
12. Advocacy and
communication
13. Surveillance
14. Cold chain
maintenance
15. General impressions
16. Additional remarks/
comments
35. Table 3. State-level training workshops/TOTs
27
Timeline
Within 3
weeks after
completion
of national
level
workshop
Trainees Trainers Duration
Data handlers: District level
HMIS and MCTS coordinators,
district computer assistant to
DIOs, District M and E focal
person (NRHM), focal person
responsible for immunization
reports in CMO office (districts to
identify and nominate least 3
persons per district)
State Immunization
Officer (SIO), State
HMIS and MCTS
coordinator, State M
and E focal
person/coordinator,
representatives from
partner organizations
such as WHO,
UNICEF and others
One day for
each
workshop
S.No.
2.
Mos: DIO and 2 MOs per district
(3 persons per district). Also
include SMOs of WHO NPSP ,
UNICEF district coordinators, and
others such as State Programme
Manager (NRHM), State IEC
Consultant, State ASHA
Coordinator, State Cold Chain
Officer, State Data Manager,
State M and E Coordinator
(NRHM), State Finance and
Accounts manager (NRHM)
SIO with support from
State CCO, HMIS and
MCTS coordinators,
IEC consultant and
partners – WHO
NPSP,UNICEF, others
1.
Don’t Forget,
accination VYour baby must get!
2.
36. S.No. Trainees Trainers Duration Timeline
28
Vaccine and cold chain handlers:
District refrigerator mechanic,
vaccine storekeeper in charge of
immunization programme at
district level (at least 2 persons
per district)
State Immunization
officer (SIO), State
cold chain officer
(CCO),
representatives from
partner organizations
such as WHO,
IEC/media handling focal
persons: Districts to identify and
nominate at least 2 persons
dealing with media and IEC for
sensitization at state level
SIO with support from
WHO, UNICEF and
other partners, State
IEC consultant, media
officer, partners
One day for
each
workshop
3.
4.
Pentavalent vaccine advocacy
and launch: Workshop for key
state/ district officials,
development partners including
media (print/ electronic)
SIO with support from
WHO, UNICEF and
other partners, State
IEC Consultant, media
officer, partners. PS to
chair and MD NRHM
to co-chair. Directors
and all CMOs should
be present
After the
national
level
workshop
(at least
2 weeks
prior to the
launch)
5.
39. Table 4. Summary of district training workshops/TOTs
S.No Trainees Trainers Duration Timeline
Notes: 1. Refer to Annexures 2, 3 and 4 for agenda and tips for trainers for Serials 1, 2 and 3
respectively.
2. Submit fortnightly progress on training status of each level of functionaries to the State Immunization
Officer.
31
1.
Master trainers: DIO
and 2 MOs trained at
state level.
Include HMIS and
MCTS staff trained at
state level.
Master trainers: DIO
and 2 MOs trained at
state level along with
district cold chain
handler, refrigerator
mechanic trained at
state level
DIO with support from
WHO, UNICEF and
other partners, district
IEC consultant, media
officer, partners
DIO with support from
WHO, UNICEF and
other partners, district
IEC consultant, media
officer. DM to chair
One day for
each
workshop
Within 2
weeks after
completion
of state-level
workshop
Within 3
weeks after
completion
of state-level
workshop
At least 2
weeks prior
to the
launch
2.
3.
4.
5.
Data handlers: Block/planning
unit to identify and nominate at
least 2 data handlers involved in
immunization data entry (HMIS
and MCTS data)per
block/planning unit. Nomination
to be forwarded to DIO
Vaccine and cold chain
handlers: Block/planning unit to
identify and nominate at least 2
persons per vaccine storage
point. Nominations to be
forwarded to DIO
IEC/media handling focal
persons: Blocks to identify and
nominate at least one person
dealing with media and IEC.
Nominations to be forwarded to
DIO
Pentavalent advocacy and
launch: Workshop for key
district/block officials,
development partners including
media (print/electronic). DIO with
support of partners to prepare the
agenda and list of invited officials
Master trainers: DIO
and 2 MOs trained at
state level
Mos: Blocks to identify and
nominate the names of at least 2
MOs per block/urban planning
unit. Nominations to be forwarded
to DIO. Others include District
Programme Manager NRHM,
District IEC Consultant, District
ASHA Coordinator, District Cold
Chain Handler, District Data
Manager, District M and E
Coordinator (NRHM), District
Accounts Manager (NRHM)
Don’t Forget,
accination VYour baby must get!
41. Table 5. Block-level training workshops/TOTs
S.No Trainees Trainers Duration Timeline
1. Health workers (ANMs, LHVs,
33
health Supervisors
District and block
master trainers
(DIO and 2 MOs trained
at state level + 2 block
level MOs trained at
district level).
They will be supported
by other trained officials
such as district/block
level data handlers,
district vaccine and cold
chain handler and
others
One day for
each
workshop
Within 3
weeks of
completion
of the
district-level
workshop
2.
Mobilizers (ASHAs and AWWs)
District and block
master trainers
DIO and 2 MOs trained
at state level + 2 block
level MOs trained at
district level.
They will be supported
by other trained officials
such ASHA
coordinators at the
district level and others
Don’t Forget,
accination VYour baby must get!
53. ANNEXURE 1
KEY FINDINGS AND RECOMMENDATIONS
OF POST-INTRODUCTION EVALUATION (PIE)
OF PENTAVALENT VACCINE IN INDIA
45
Don’t Forget,
accination VYour baby must get!
56. ANNEXURE 2
PENTAVALENT VACCINE
TRAINING WORKSHOP FOR MEDICAL
OFFICERS AT STATE/DISTRICT LEVEL
Table 1. Pentavalent vaccine training workshop for medical officers
Agenda for pentavalent vaccine training workshop for medical officers
Time Activity Person/s responsible
Note: Person/s responsible for conducting training to be decided at the local level
48
Total time: 6 hours
Registration
15 min Objectives of the workshop and opening remarks
15 min Basic facts about pentavalent vaccine
20 min Current and revised vaccination schedule
20 min Concept of “phasing in”, “phasing out” and
repositioning of vaccine
15 min Introduction to the immunization component of the
MCP card /counterfoil and its use through tracking bag
20 min Understanding “full immunization” and “complete
immunization”
30 min Use of coverage monitoring chart, including
demonstration of the tool.
30 min Update on revised data entry tools and logistic
requirements (MCP cards, tally sheets, MCH
registers, HMIS/MCTS formats)
15 min Entry of pentavalent vaccine in HMIS and MCTS
portals
20 min Coverage trends after pentavalent vaccine
Introduction, and actions required
20 min National Cold Chain Management Information
System(NCCMIS) status
20 min FAQs on pentavalent vaccine
20 min Vaccine safety (AEFI) and immunization waste
management
30 min What to do after this workshop: role in sensitizing
the health workforce
15 min Interaction about way forward
Wrap up
59. ANNEXURE 3
PENTAVALENT VACCINE
TRAINING WORKSHOP FOR DATA
HANDLERS AT STATE/DISTRICT LEVEL
Table 2. Pentavalent vaccine training workshop for data handlers
Agenda for pentavalent vaccine training workshop for data handlers
Time Activity Person/s responsible
Note: Person/s responsible for conducting training to be decided at the local level
51
Total time: 6 hours
Registration
15 min Objective of the workshop and opening remarks
15 min Basic facts about pentavalent vaccine
20 min Current and revised vaccination schedule
20 min Concept of “phasing in”, “phasing out” and
repositioning of vaccine
20 min Understanding “full immunization” and “complete
immunization”
30 min Use of coverage monitoring chart. Demonstrate tool
for analysis
30 min Update on revised data entry tools and logistic
requirements (MCP cards, tally sheet, MCH registers,
HMIS / MCTS formats)
15 min Entry of pentavalent vaccination in HMIS and MCTS
portals
20 min Coverage trends after pentavalent vaccine
introduction, and actions required
15 min Assessing immunization performance: physical and
financial
15 min NCCMIS status15 minFAQs on pentavalent vaccine
30 min What to do after this workshop: role in training the
data handlers
Wrap up
Don’t Forget,
accination VYour baby must get!
62. ANNEXURE 4
PENTAVALENT VACCINE TRAINING
WORKSHOP FOR VACCINE AND
COLD CHAIN HANDLERS AT
STATE/DISTRICT LEVEL
Table 3. Pentavalent vaccine training workshop for
vaccine and cold chain handlers
Agenda for pentavalent vaccine training workshop
vaccine and cold chain handlers
Note: Person/s responsible for conducting training to be decided at the local level
54
Person/s responsible
65. ANNEXURE 5
PENTAVALENT VACCINE
TRAINING WORKSHOP FOR ANMS,
LHVS AND HEALTH SUPERVISORS AT
BLOCK LEVEL
Table 4. Pentavalent vaccine training workshop for ANMs,
LHVs and health supervisors
Agenda for pentavalent vaccine training workshop for ANMs,
LHVs and health supervisors
Time Activity Person/s responsible
57
Total time: 6 hours
Registration
10 min Objectives of workshop and opening remarks
20 min Basic facts about pentavalent vaccine
20 min Current and revised vaccination schedule
20 min FAQs on pentavalent vaccine
30 min Introduction to the immunization component of the MCP
card. Filling and use of counterfoil and its use through
tracking bag
Understanding “full immunization” and “complete
immunization”
20 min Improving microplanning. Emphasize on including polio
HRA as part of the microplan and estimation of
beneficiaries concept
30 min Use of immunization tracking bag and due list for tracking
30 min Learning to make sub-centre level coverage monitoring
chart. Ask participants to bring their annual target of
infants and month-wise DPT 1 and DPT 3 dose
coverage for the past 6 months
30 min Revised logistics update (registers/MCP cards/tally
sheets, MCH registers, HMIS / MCTS formats/ IEC
material)
15 min Where does an ANM enter data for pentavalent
vaccination in the HMIS and MCTS registers/formats?
20 min Discuss about how coverage of DPT, hepatitis B and
pentavalent vaccine will change when pentavalent
vaccine is introduced
Don’t Forget,
accination VYour baby must get!
66. 15 min Importance of ensuring open vial policy for DPT,TT,
hepatitis B and pentavalent vaccine is in place through
alternate vaccine delivery
10 min Explain how monitoring will intensify for vaccines
distribution and return of unused/partial vaccines on the
day of immunization
20 min Vaccine safety (AEFI) and immunization waste
management. Explain reporting/management guidelines
30 min What to do after this workshop: their role in sensitizing
the social mobilizers: ASHAs and AWWs
Note: Person/s responsible for conduct of training to be decided at the local level
58
15 min Interaction about way forward
Wrap up
69. ANNEXURE 6
PENTAVALENT VACCINE
TRAINING WORKSHOP FOR
ASHAS/AWWS/LINK WORKERS
AT BLOCK LEVEL
Table 5. Pentavalent vaccine training workshop for
ASHAs/AWWs/link workers
Agenda for pentavalent vaccine training workshop
ASHA, AWW and link workers
Time Activity Person/s responsible
Note: Person/s responsible for conducting training to be decided at the local level
61
Total time: 6 hours
Registration
10 min Objectives of the workshop and opening remarks
10 min Basic facts about pentavalent vaccine
10 min Current and revised vaccination schedules
30 min Introduction to the immunization component of the
MCP card; filling and using the counterfoil and its use
through tracking bag; understanding “full
immunization” and “complete immunization”
10 min Improving microplanning, emphasizing on estimation
of beneficiaries by ASHAs/AWWs in their
catchment area
30 min Use of immunization tracking bag and helping to
prepare due lists for tracking
10 min New IEC materials related to pentavalent vaccine
and how to display them.
10 min Explain to them as to how coverage of DPT, hepatitis
B and pentavalent vaccine will change once
pentavalent vaccine is introduced
30 min Key messages regarding pentavalent vaccine that
ASHAs/AWWs must understand for improving
vaccine coverage in the field. Emphasize on
pentavalent vaccine messages (less pricks, more
antigens – force of five in one)
15 min Interaction about way forward
Wrap up
Don’t Forget,
accination VYour baby must get!
72. ANNEXURE 7
PENTAVALENT VACCINE
TRAINING WORKSHOP FOR IEC/MEDIA
HANDLING FOCAL PERSONS
Table 6. Pentavalent vaccine training workshop for IEC/media
handling focal persons
Pentavalent vaccine training workshop
IEC/media handling focal persons
Person/s responsible
64
Person/s responsible
Total time: 6 hours
Time Activity
Registration
10 min Objectives of the workshop and opening remarks
Expected role of the participants in the programme
30 min Understanding immunization status at national, state
and district levels
Explain “full immunization” and “complete
immunization”
Situational analysis:
- Current status (evaluated coverage : Annual Health
Survey (AHS) or District Level Household Survey
(DLHS); compare with the previous evaluated
coverage; explain the progress with focus on districts
- Status of high priority districts (RMNCH+A), blocks
and groups (polio HRAs)
- Current strengths and challenges in immunization
program at state and district level
- Understanding the issues and efforts related to the
unreached. Tagging of polio HRAs in RI microplan
- Mobilization efforts, incentives available for ASHA
20 min Status of state and district preparedness for
pentavalent vaccine introduction (are districts/blocks
ready?)
Key findings and state efforts to improve the gaps
20 min Basic facts about pentavalent vaccine
How would current vaccination schedule change after
introduction of pentavalent introduction?
73. 20 min Key FAQs (refer to operational guidelines):
Note: Person/s responsible for training to be decided at the local level.
65
- Hib disease
- Pentavalent vaccine
20 min Additional questions that media/participants are likely
to raise. (Participants should be encouraged to ask
questions; facilitator to note these questions on the flip
chart and then address them one by one).
20 min Increasing visibility of the RI program in state with a
focus on pentavalent vaccine introduction.
Demonstrate the new IEC prototypes along with state
instructions
20 min Role of media, (print, electronic and social) in
pentavalent vaccine introduction. Disseminate state
specific instructions
30 min Risk communication (basics for handling an AEFI
crisis – refer MoH communication guidelines for
building vaccine confidence around AEFI)
45 min How to write a press release
Essentials of a press conference
Key points to remember for conducting a press
conference including essential documents needed
during the conference
30 min Existing mechanism to monitor RI programme in
states. State-specific efforts to monitor the visibility of
RI in states. Discuss about any evaluation data (if
available)
Monitoring state IEC/ behavior change communication
(BCC) efforts. Discuss and disseminate relevant
formats and process of data entry, if any. If it does not
exist, plan to institutionalize the same
20 min IEC/BCC: Issues/challenges that participants foresee
in new vaccine introduction and practical solutions at
their level
15 min Based on pentavalent operational guidelines:
- Activities (training) planned to be completed before
vaccine introduction (who trains whom and at what
level)
Explain the role of participants in:
- training the IEC/media handling officials (at least 2
per block/planning unit)
- planning the launch of the workshop including the
media briefing, press release, etc.
Wrap up
Don’t Forget,
accination VYour baby must get!